These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17979738)

  • 21. Antivenoms for the treatment of snakebite envenomings: the road ahead.
    Gutiérrez JM; León G; Burnouf T
    Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenom therapy in the Americas.
    Heard K; O'Malley GF; Dart RC
    Drugs; 1999 Jul; 58(1):5-15. PubMed ID: 10439926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering and design considerations for next-generation snakebite antivenoms.
    Knudsen C; Ledsgaard L; Dehli RI; Ahmadi S; Sørensen CV; Laustsen AH
    Toxicon; 2019 Sep; 167():67-75. PubMed ID: 31173790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pioneers of venom production for Australian antivenoms.
    Mirtschin P
    Toxicon; 2006 Dec; 48(7):899-918. PubMed ID: 16938322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priority Actions and Progress to Substantially and Sustainably Reduce the Mortality, Morbidity and Socioeconomic Burden of Tropical Snakebite.
    Harrison RA; Gutiérrez JM
    Toxins (Basel); 2016 Nov; 8(12):. PubMed ID: 27886134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of snakebite burdens, clinical features of envenomation, and strategies to improve snakebite management in Vietnam.
    Patra A; Mukherjee AK
    Acta Trop; 2021 Apr; 216():105833. PubMed ID: 33485869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of laboratory-based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation.
    Patra A; Herrera M; Gutiérrez JM; Mukherjee AK
    Drug Test Anal; 2021 Aug; 13(8):1471-1489. PubMed ID: 34089574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in diagnostic tools and bioanalytical methods for analysis of snake venom: A critical review.
    Puzari U; Mukherjee AK
    Anal Chim Acta; 2020 Nov; 1137():208-224. PubMed ID: 33153604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects of snakebite envenoming and its treatment in low-resource settings.
    Warrell DA; Williams DJ
    Lancet; 2023 Apr; 401(10385):1382-1398. PubMed ID: 36931290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of snakebite poisoning.
    Smith TA; Figge HL
    Am J Hosp Pharm; 1991 Oct; 48(10):2190-6. PubMed ID: 1781479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could this be snakebite?
    Hawdon GM; Winkel KD
    Aust Fam Physician; 1997 Dec; 26(12):1386-91, 1393-4. PubMed ID: 9470292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A locally developed snakebite management protocol significantly reduces overall anti snake venom utilization in West Bengal, India.
    Ghosh S; Maisnam I; Murmu BK; Mitra PK; Roy A; Simpson ID
    Wilderness Environ Med; 2008; 19(4):267-74. PubMed ID: 19099337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alarmins and inflammatory aspects related to snakebite envenomation.
    Zuliani JP
    Toxicon; 2023 Apr; 226():107088. PubMed ID: 36924999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The global snakebite crisis--a public health issue misunderstood, not neglected.
    Simpson ID; Norris RL
    Wilderness Environ Med; 2009; 20(1):43-56. PubMed ID: 19364169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management.
    Boldrini-França J; Corrêa-Netto C; Silva MM; Rodrigues RS; De La Torre P; Pérez A; Soares AM; Zingali RB; Nogueira RA; Rodrigues VM; Sanz L; Calvete JJ
    J Proteomics; 2010 Aug; 73(9):1758-76. PubMed ID: 20542151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of snake venoms and development of new therapeutics.
    Sánchez EE; Rodríguez-Acosta A
    Immunopharmacol Immunotoxicol; 2008; 30(4):647-78. PubMed ID: 18686104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of the immune modulating effects of enzymatic toxins from snake venoms.
    Burin SM; Menaldo DL; Sampaio SV; Frantz FG; Castro FA
    Int J Biol Macromol; 2018 Apr; 109():664-671. PubMed ID: 29274419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
    Laustsen AH; Johansen KH; Engmark M; Andersen MR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.